NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers (NTCDU)

Stopped The NO-002 study had to be paused because of enrollment disruptions due to the current situation in Israel, and concerns over the placebo batch stability results.

Conditions

• Diabetic Foot Ulcer

Interventions

• DRUG: NOX-1416+SOC
• OTHER: Placebo+SOC

Sponsor

NOxy Health Products, LLC